C-Rad
32.80 SEK
+1.39 %
Less than 1K followers
CRAD B
NASDAQ Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+1.39 %
+2.34 %
+2.50 %
-3.67 %
+9.33 %
+8.97 %
-8.38 %
-15.57 %
+152.61 %
C-Rad operates in the medical technology industry and focuses on the development and manufacture of systems for radiation therapy of cancer. The company's products are aimed at healthcare institutions and oncologists. The business is present on a global level, with a main presence in Europe, North America and Asia. C-Rad was founded in 2004 and is headquartered in Uppsala, Sweden.
Read moreMarket cap
1.11B SEK
Turnover
239.7K SEK
Revenue
469M
EBIT %
14.93 %
P/E
19.64
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
12.2
2026
Annual report '25
6.5
2026
Interim report Q1'26
7.5
2026
General meeting '26
All
Webcasts
Press releases
3rd party
ShowingAll content types
C-RAD has decided to repurchase own class B shares
C-RAD ABs Interim Report Q3 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
